Mark Aguillard

Mark Aguillard

Corporate Officer/Principal bei DERMTECH, INC.

Vermögen: 28 350 $ am 31.05.2024

Health Technology
Consumer Services
Technology Services

Ursprung des Netzwerks ersten Grades von Mark Aguillard

EinheitArt der EinheitIndustrie
Public Company Medical Specialties 18
1
Holding Company Medical Specialties 1
1
Holding Company Information Technology Services 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Mark Aguillard

UnternehmenSektorVerknüpfte PersonenHauptposition
Wireless Telecommunications

Steve Kunszabo

Investor Relations Contact

VIVUS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

MYRIAD GENETICS, INC. Medical Specialties

Mark Capone

Bret Christensen

Loren Clarke

Steven Stone

Chief Executive Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Medical Specialties

Kirk Malloy

Matthew Posard

Kevin Sun

Chief Tech/Sci/R&D Officer

Sales & Marketing

Corporate Officer/Principal

ILLUMINA, INC. Biotechnology

Kirk Malloy

Matthew Posard

Corporate Officer/Principal

Corporate Officer/Principal

HALOZYME THERAPEUTICS, INC. Biotechnology

Matthew Posard

Director/Board Member

Medical Specialties

Matthew Posard

Herm Rosenman

Sales & Marketing

Director of Finance/CFO

MEDISTEM INC Medical Specialties

Herm Rosenman

Director/Board Member

Medical/Nursing Services

Burkhard Jansen

Chief Executive Officer

ORGANOVO HOLDINGS, INC. Biotechnology

Kirk Malloy

Steve Kunszabo

Chairman

Investor Relations Contact

OXFORD IMMUNOTEC GLOBAL PLC Medical Specialties

Herm Rosenman

Director/Board Member

Investment Managers

Herm Rosenman

Chief Executive Officer

ARYX THERAPEUTICS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

DEXCOM, INC. Medical Specialties

Kevin Sun

Rachel Williams

Director of Finance/CFO

Corporate Officer/Principal

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Medical Specialties

Cynthia Collins

Matthew Posard

Herm Rosenman

Burkhard Jansen

James Rock

Claudia Ibarra

Kevin Sun

Director/Board Member

Chairman

Director/Board Member

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Chief Operating Officer

Director of Finance/CFO

CARDIFF ONCOLOGY, INC. Medical Specialties

Matthew Posard

Corporate Officer/Principal

Pace University College/University

Herm Rosenman

Undergraduate Degree

University of California San Diego College/University

Matthew Posard

Undergraduate Degree

University of Vienna College/University

Burkhard Jansen

Corporate Officer/Principal

Medical Specialties

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Miscellaneous Commercial Services

David King

Mark Capone

Chairman

Director/Board Member

Packaged Software

Matthew Posard

Director/Board Member

NATERA, INC. Medical Specialties

Herm Rosenman

Director/Board Member

Ultra Acquisition Corp.

Herm Rosenman

Chief Executive Officer

Electronic Production Equipment

Herm Rosenman

Founder

IRIDIUM COMMUNICATIONS INC. Specialty Telecommunications

Steve Kunszabo

Investor Relations Contact

Medical Specialties

Herm Rosenman

Director/Board Member

Medical/Nursing Services

Herm Rosenman

Director/Board Member

DERMIRA, INC. Pharmaceuticals: Major

Ray Bassi

Sales & Marketing

Packaged Software

Matthew Posard

President

The Wharton School of the University of Pennsylvania College/University

Herm Rosenman

Masters Business Admin

Miscellaneous Commercial Services

Matthew Posard

Director/Board Member

NIRI San Diego

Steve Kunszabo

Director/Board Member

Packaged Software

Matthew Posard

Director/Board Member

Information Technology Services

Cynthia Collins

Director/Board Member

TALIS BIOMEDICAL CORPORATION Medical Specialties

Matthew Posard

Director/Board Member

Biotechnology

Matthew Posard

Director/Board Member

Miscellaneous Commercial Services

Matthew Posard

Chairman

Information Technology Services

Matthew Posard

Chairman

NAUTILUS BIOTECHNOLOGY, INC. Biotechnology

Matthew Posard

Chairman

Explore DNA

Matthew Posard

Corporate Officer/Principal

Panavance Therapeutics, Inc.

Cynthia Collins

Director/Board Member

METACRINE, INC. Biotechnology

Steve Kunszabo

Investor Relations Contact

Statistik

International

Vereinigte Staaten 48
Vereinigtes Königreich 3
Österreich 2

Sektoral

Health Technology 25
Commercial Services 6
Technology Services 6
Consumer Services 5
Communications 3

Operativ

Director/Board Member 85
Corporate Officer/Principal 36
Independent Dir/Board Member 23
Chairman 18
Director of Finance/CFO 17
  1. Börse
  2. Insiders
  3. Mark Aguillard
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT